Shaping Convergent Strategies in Comparative Effectiveness Research
Co-Sponsored by the National Pharmaceutical Council, America's Health Insurance Plans, Blue Cross Blue Shield Association
The Patient Protection and Affordable Care Act created a new national comparative effectiveness research institute. This meeting examined implications for pharmaceutical firms, health plans, delivery systems, and consumers, and explored strategies for ensuring that new research is effectively targeted, methodologically sound, and actionable for decision makers.
Presentations
The Patient-Centered Outcomes Research Institute (PCORI)
Carolyn M. Clancy, MD
Comparative Effectiveness Research: Large Employers’ Perspective
Helen Darling
Comparative Effectiveness Research and Policy Development
Douglas Hadley, MD
What Make Comparative Effectiveness Data Compelling?
Barbara J. McNeil, MD, PhD
Defining Good Evidence to Inform Decision-Making and Ensure the Delivery of High Value Health Care Services
Les Paul, MD, MS
Comparative Effectiveness Research: Informing Public and Private Payer Decision-Making
Brian Sweet
Methodological Guidance for Comparing Health Interventions
Sean Tunis, MD, MSc
Comparative Effectiveness Research: Initial Success, Future Challenges
Gail R. Wilensky
CER: Informing Public and Private Decision-Making
Charles Yarborough, MD, MPH, FACOEM, FACPM